Here are three highlights:
1. The Incision-less Anastomosis System facilitates a non-surgical procedure that treats Type 2 diabetes in obese patients.
2. Christopher C. Thompson, MD, director of developmental endoscopy at Brigham and Women’s Hospital in Boston, is the founder of GI Windows.
3. GI Windows is a West Bridgewater, Mass.-based clinical-stage medical device company that develops non-surgical procedures for Type 2 diabetes and other metabolic diseases.
More articles on GI & endoscopy:
Gastroenterologist to know: Dr. Matthew Bechtold of University of Missouri Health School of Medicine
4 GI physicians in the news — May 13, 2016
Synthetic Biologics names Dr. Isaac Bright VP: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.